PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Functional Genetics, Inc. announced today that it has received two different awards from the United States Defense Threat Reduction Agency for the discovery and development of therapeutics for Ebola virus and other viral pathogens.
"These awards from DTRA will greatly assist our mission of discovering... - December 01, 2006 - Functional Genetics, Inc.
Have you seen them yet? Blue Ribbons are making their way around the world, literally homeward bound to dozens of countries worldwide. Launched this past week by the Malaria Foundation International (MFI) as a universal symbol in the fight against malaria, Blue Ribbons with the message End Malaria... - November 20, 2006 - Malaria Foundation International
Who could object? Malaria finally has a symbol representing the fight against this deadly disease, which kills 3,000 people each day. Business leaders and community groups are called to action. This is no longer a silent disease. “We are gaining momentum, and no one will want to be left out. Everyone... - November 13, 2006 - Malaria Foundation International
Hudson Pride Connections and New York Researchers at Hunter College Announce Creation of a New Program to Reduce HIV / AIDS Rates Among Transgender Women and Lead the Way for Similar Future Programs - October 25, 2006 - Hudson Pride Connections
InViragen, LLC, a biotechnology company dedicated to developing vaccines for emerging infectious diseases worldwide, has entered into an Exclusive Patent License Agreement with the Centers for Disease Control and Prevention (CDC). The licensed technology is applicable to vaccines against multiple viral diseases, including dengue fever and West Nile disease. Dengue fever threatens 2.5 billion people worldwide as well as travelers to tropical countries. - September 14, 2006 - Colorado BioScience Association
Malaria Foundation International honors unsung heroes and leaders in science, business, education, sports, entertainment and the media in the fight against malaria. Award recipients are listed with more detailed information and web links available at www.malaria.org. The MFI congratulates the many individuals and organizations worldwide for their current accomplishments in the fight against malaria and looks forward to its 2007 awards. - September 04, 2006 - Malaria Foundation International
Controlling an outbreak of H5N1 Avian Flu, SARS, or BSE is becoming a reality thanks to patentable tracking technologies emerging from AgroMicron, Ltd. - September 02, 2006 - AgroMicron
For those concerned about the much-hyped threat of Asian bird flu, there are preventative measures. Reduce the risk of contamination with one easy solution. - July 31, 2006 - Pure Air Systems
The Malaria Foundation International (MFI) announces the 2006 Inaugural Malaria Awards. Congratulations to the many individuals and organizations who have made exceptional progress in the fight against malaria. The inaugural awards highlight major achievements and events from 2005. - July 15, 2006 - Malaria Foundation International
Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association
Healthcare professional, Stacey Lloyd, is offering a free webinar to discuss the risks of contracting tuberculosis during air travel at www.StaceyLloyd.com. This webinar will be available to air travelers and healthcare personnel during the busy travel season. - June 20, 2006 - Pharmaceutical Resources Group
The Canadian scientist who played a pivotal role in the development of lamivudine for the treatment of hepatitis B virus is now pursuing how to make the antiviral drug more effective. His company’s new Chimigen™ platform, which he believes could help overcome the antiviral drug’s shortfalls, might open the door for treating other infectious diseases, and possibly cancer. - May 31, 2006 - StockInterview.com
The Malaria Foundation International (MFI) is proud to announce the first ever Malaria Awards Ceremony, to be held in Atlanta, Georgia, USA on May 18, 2006. The first annual awards ceremony will be entertaining, educational and empowering as it creates a special annual day to honor the hundreds of individuals and organizations who are spearheading the world’s fight against malaria. Nominations are now being accepted for 50+ categories. - January 23, 2006 - Malaria Foundation International
A four-hour webcast opened today at the Malaria Foundation International (MFI) website. A prestigious and diverse line up of speakers (29 in total) succeed in engaging a captivated audience. Malaria kills millions, mostly children, year after year, and the conference aimed to help bring this message to the forefront and help bring an end to these “quiet deaths,” which minute by minute, year after year have gone largely unnoticed worldwide. - December 24, 2005 - Malaria Foundation International
December 6, 2005 at Emory University in Atlanta will mark an historic meeting, open to the public (see www.malaria.org, the Malaria Foundation International website, to register). Malaria fighters will gather from 2:30 pm to 7:30 pm to launch Atlanta’s first annual “Hedge Funds vs. Malaria” business leadership conference, in the Tull Auditorium of Emory’s Law School. Each day, thousands of children die from malaria, a completely preventable and treatable disease. New action is sought. - December 04, 2005 - Malaria Foundation International